Evidence map›Paper›PMID 30415489›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

L G Poole, A Pant, K S Baker, A K Kopec, H M Cline-Fedewa, S E Iismaa, M J Flick, J P Luyendyk

Abstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Altered fibrinogen γ-chain cross-linking in mutant fibrinogen-γJournal of thrombosis and haemostasis : JTH · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

L G PooleInstitute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
A PantInstitute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
K S BakerInstitute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
A K KopecInstitute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.
H M Cline-FedewaDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA.
S E IismaaDivision of Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.
M J FlickCancer and Blood Diseases Institute, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
J P LuyendykInstitute for Integrative Toxicology, Michigan State University, East Lansing, MI, USA.ORCID 0000-0002-3503-7140
Michigan State University · USCincinnati Children's Hospital Medical Center · USVictor Chang Cardiac Research Institute · AU

Funding

MULTIDISCIPLINARY TRAINING IN ENVIRONMENTAL TOXICOLOGYT32ES007255 · NIEHS · MICHIGAN STATE UNIVERSITY · PI JOHN J LAPRES · 1989 to 2026
$9.3M
Novel anti-fibrotic mechanisms in chemical-induced liver injuryR01ES017537 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUYENDYK, JAMES P · 2009 to 2019
$3.6M
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma diseaseR01CA211098 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLICK, MATTHEW J. · 2017 to 2022
$2.2M
Integrative Training in the Pharmacological SciencesT32GM092715 · NIGMS · MICHIGAN STATE UNIVERSITY · PI NEUBIG, RICHARD R · 2011 to 2020
$1.5M
RISK MANAGEMENT IN NATIVE AMERICAN COMMUNITIESR25ES007255 · NIEHS · CLARK UNIVERSITY (WORCESTER, MA) · PI GOBLE, ROBERT L · 1994 to 2002
$738k
NCI NIH HHS R01 CA211098NIEHS NIH HHS R01 ES017537NIEHS NIH HHS R25 ES007255NIEHS NIH HHS T32 ES007255NIGMS NIH HHS T32 GM092715
6 · The paper itself

Abstract

Essentials Fibrin clots are often implicated in the progression of liver fibrosis. Liver fibrosis was induced in transgenic mice with defects in clot formation or stabilization. Liver fibrosis and fibrin(ogen) deposition do not require fibrin polymerization or factor XIIIa. Fibrin(ogen) is an in vivo substrate of tissue transglutaminase in experimental liver fibrosis. SUMMARY: Background Intravascular fibrin clots and extravascular fibrin deposits are often implicated in the progression of liver fibrosis. However, evidence supporting a pathological role of fibrin in hepatic fibrosis is indirect and based largely on studies using anticoagulant drugs that inhibit activation of the coagulation protease thrombin, which has other downstream targets that promote fibrosis. Therefore, the goal of this study was to determine the precise role of fibrin deposits in experimental hepatic fibrosis. Methods Liver fibrosis was induced in mice expressing mutant fibrinogen insensitive to thrombin-mediated proteolysis (i.e. locked in the monomeric form), termed Fib

Indexed as

AnimalsCarbon TetrachlorideChemical and Drug Induced Liver InjuryCollagen Type ICollagen Type I, alpha 1 ChainFactor XIIIFactor XIIIaFactor XIII DeficiencyFemaleFibrinogenGTP-Binding ProteinsLiverLiver Cirrhosis, ExperimentalMice, Inbred C57BLMice, KnockoutProtein Glutamine gamma Glutamyltransferase 2Carbon TetrachlorideCollagen Type ICollagen Type I, alpha 1 ChainFactor XIIIFactor XIIIafactor XIII subunit AFibrinogenGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminasescoagulationfactor XIIIfibrinfibrosisthrombin

Identifiers

PMID30415489
PMCPMC6322974
OpenAlexW2900355193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.